This episode currently has no reviews.
Submit ReviewTo make informed decisions about our health, we have to break taboos against publicly discussing our basic bodily functions - and most perplexing symptoms. Ladyparts takes a wide view, attempting to bridge the divide between mainstream medicine and holistic healthcare, and consider all of our options.
The reproductive disorder endometriosis affects one in ten women. It can cause debilitating periods, pelvic pain and infertility. Endometriosis is most often treated with birth control pills or surgery. But this summer, the FDA approved the first ever medication formulated specifically to treat this disease. Elagolix, or Orilissa, suppresses the estrogen that fuels endometriosis, without putting the body into a full-blown menopausal state, as older drugs did. Yet expert disagree on its efficacy. And with a price tag of $1000 a month, is Orilissa worth it?
Guests:
Caitlin McDonough, endometriosis patient and advocate
Hugh Taylor, MD, reproductive endocrinologist, chief of OBGYN at Yale- New Haven Hospital and endometriosis researcher
David Redwine, MD, founder of the Oregon Institute of Endometriosis at St. Charles Medical Center, Bend, Oregon and expert in endometriosis surgery
Resources:
Report from phase III elagolix trials, New England Journal of Medicine
review.org/wp-content/uploads/2017/12/ICER_Elagolix_Final_Evidence_Report_080318.pdf">ICER report on clinical and economic effectiveness of elagolix, full text
review.org/wp-content/uploads/2018/08/ICER_Endometriosis_RAAG_080318.pdf">ICER report, at-a-glance version
Endometriosis patient information and advocacy:
endopaedia.info (Dr. Redwine’s website)
periods.com">Bad-periods.com
[Endometropolis Facebook group] (this is a private patient group, you must request access)
Credits:
Ladyparts is hosted and produced by Andrea Muraskin, with editing help this week from Jenn Stanley. Special thanks to Casey Berna and Lucy Gellman. The Ladyparts logo is by Jamie Squire. Our theme song is by Adam Ragusea. Other music in this episode was provided by Blue Dot Sessions.
Get in touch/share:
Website: ladypartspod.com
Twitter: @Andrea_Muraskin
IG: @andreamuraskin
Email: ladypartsradio@gmail.com
Please rate and review!
To make informed decisions about our health, we have to break taboos against publicly discussing our basic bodily functions - and most perplexing symptoms. Ladyparts takes a wide view, attempting to bridge the divide between mainstream medicine and holistic healthcare, and consider all of our options.
The reproductive disorder endometriosis affects one in ten women. It can cause debilitating periods, pelvic pain and infertility. Endometriosis is most often treated with birth control pills or surgery. But this summer, the FDA approved the first ever medication formulated specifically to treat this disease. Elagolix, or Orilissa, suppresses the estrogen that fuels endometriosis, without putting the body into a full-blown menopausal state, as older drugs did. Yet expert disagree on its efficacy. And with a price tag of $1000 a month, is Orilissa worth it?
Guests:
Caitlin McDonough, endometriosis patient and advocate
Hugh Taylor, MD, reproductive endocrinologist, chief of OBGYN at Yale- New Haven Hospital and endometriosis researcher
David Redwine, MD, founder of the Oregon Institute of Endometriosis at St. Charles Medical Center, Bend, Oregon and expert in endometriosis surgery
Resources:
Report from phase III elagolix trials, New England Journal of Medicine
review.org/wp-content/uploads/2017/12/ICER_Elagolix_Final_Evidence_Report_080318.pdf">ICER report on clinical and economic effectiveness of elagolix, full text
review.org/wp-content/uploads/2018/08/ICER_Endometriosis_RAAG_080318.pdf">ICER report, at-a-glance version
Endometriosis patient information and advocacy:
endopaedia.info (Dr. Redwine’s website)
periods.com">Bad-periods.com
[Endometropolis Facebook group] (this is a private patient group, you must request access)
Credits:
Ladyparts is hosted and produced by Andrea Muraskin, with editing help this week from Jenn Stanley. Special thanks to Casey Berna and Lucy Gellman. The Ladyparts logo is by Jamie Squire. Our theme song is by Adam Ragusea. Other music in this episode was provided by Blue Dot Sessions.
Get in touch/share:
Website: ladypartspod.com
Twitter: @Andrea_Muraskin
IG: @andreamuraskin
Email: ladypartsradio@gmail.com
Please rate and review!
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review